The influence of diabetes mellitus on postoperative infections

Critical Care Nursing Clinics of North America

Volumn 15, Issue 1, 2003, Pages 125-135

  Aragon, Daleen ^a   Ring, C Allan ^b   Covelli, Maureen ^b  

^a ORLANDO HEALTH   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; INSULIN;

CHEMOTAXIS; CLINICAL TRIAL; DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; IMMUNE SYSTEM; IMMUNOCOMPETENCE; INFECTION RISK; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OPSONIZATION; POSTOPERATIVE INFECTION; REVIEW; STRESS; IMMUNE DEFICIENCY; IMMUNOLOGY; MICROBIOLOGY; NURSING; NURSING ASSESSMENT; SURGICAL INFECTION;

DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; IMMUNOCOMPROMISED HOST; NURSING ASSESSMENT; STRESS; SURGICAL WOUND INFECTION;

EID: 0037365658     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-5885(02)00036-9     Document Type: Review

References (36)

1. American Diabetes Association. Facts and figures. Available at: www.diabetes.org. Accessed May 1, 2002
2. Flynn M.B. Wound healing and critical illness. Crit Care Clin. 8:(2):1996;115-123
3. Joshi N., Caputo G.M., Weitekamp M.R., Karchmer A.W. Infections in patients with diabetes mellitus. N Engl J Med. 341:(25):1999;1906-1912
4. Meyer J.S. Diabetes and wound healing. Crit Care Clin. 8:(2):1996;195-201
5. Silhi N. Diabetes and wound healing. J Wound Care. 7:(1):1998;47-51
6. Kamal K., Powell R.J., Sumpio B.E. The pathobiology of diabetes mellitus: implications for surgeons. J Am Coll Surg. 183:(3):1996;271-289
7. Sima A.A.F., O'Neill S.J., Naimark D., et al. Bacterial phagocytosis and intracellular killing by alveolar macrophages in BB rats. Diabetes. 37:1988;544-549
8. Boyko E.J., Lipsky B.A. Infection and diabetes. Harris M.I., Cowie C.C., Stern M.P., et al. Diabetes in America (NIH Publication No. 95-1468). 2nd edition:1995;485-499 US Government Printing Office, Washington, DC
9. Löe H., Genco R.J. Oral complications in diabetes. Harris M.I., Cowie C.C., Stern M.P., et al. Diabetes in America (NIH Publication No. 95-1468). 2nd edition:1995;501-506 US Government Printing Office, Washington, DC
10. McMahon M.M., Bistrian B.R. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am. 9:(1):1995;1-9
11. Jones R.E., Huether S.E. The immune system. McCance K.L., Huether S.E. Pathophysiology: the biologic basis for disease in adults and children. 4th edition:2002;640-657 Mosby, St. Louis
12. Rayfield E.J., Ault M.J., Keusch G.T., et al. Infection and diabetes: the case for glucose control. Am J Med. 72:1982;439-450
13. Eastman R.C. Neuropathy in diabetes. Harris M.I., Cowie C.C., Stern M.P., et al. Diabetes in America (NIH Publication No. 95-1468). 2nd edition:1995;339-348 US Government Printing Office, Washington, DC
14. Friedman E.A. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care. 22:1999;B65-B71
15. Furth A.J. Glycated proteins in diabetes. Br J Biomed Sci. 54:1997;192-200
16. Sano H., Nagai R., Matsumoto K., et al. Receptors for proteins modified by advanced glycation end products (AGE)-their functional role in atherosclerosis. Mech Ageing Dev. 107:1999;333-346
17. Masuda M., Murakami T., Egawa H., Murata K. Decreased fluidity of polymorphonuclear leukocyte membrane in streptozocin-induced diabetic rats. Diabetes. 39:1990;466-470
18. Black C.T., Hennessey P.J., Andrassy R.J. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma. 30:(7):1990;830-833
19. Hennessey P.J., Black C.T., Andrassy R.J. Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation. Journal of Parenteral and Enteral Nutrition. 15:(1):1991;60-63
20. Foster D.W., McGarry D.J. Glucose, lipid, and protein metabolism. Griffin J.E., Ojeda S.R. Textbook of endocrine physiology. 2000;393-419 Oxford University Press, New York
21. Borger M.A., Rao V., Weisel R.D., et al. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg. 65:(4):1998;1050-1056
22. Casey J., Flinn W.R., Yao J.S., et al. Correlation of immune and nutritional status with wound complications in patients undergoing vascular operations. Surgery. 93:(6):1983;822-827
23. Gadaleta D., Risucci D.A., Nelson R.L., et al. Effects of morbid obesity and DM mellitus on risk of coronary artery bypass grafting. Am J Cardiol. 70:(20):1992;1613-1614
24. Golden S.H., Peart-Vigilance C., Kao W.H., Brancati F.L. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 22:(9):1999;1408-1414
25. Mullen J.C., Bentley M.J., Mong K., et al. Reduction of leg wound infections following coronary artery bypass surgery. Can J Cardiol. 15:(1):1999;65-68
26. Richet H.M., Chidiac C., Prat A., et al. Analysis of risk factors for surgical wound infections following vascular surgery. Am J Med. 91:(3B):1991;170S-172S
27. Spelman D.W., Russo P., Harrington G., et al. Risk factors for surgical wound infection and bacteraemia following coronary artery bypass surgery. Aust N Z J Surg. 70:(1):2000;47-51
28. Trick W.E., Scheckler W.E., Tokars J.I., et al. Risk factors for radial artery harvest site infection following coronary artery bypass graft surgery. Clin Infect Dis. 30:(2):2000;270-275
29. Trick W.E., Scheckler W.E., Tokars J.I., et al. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 119:(1):2000;108-114
30. Vuorisalo S., Haukipuro K., Pokela R., Syrjälä H. Risk features for surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol. 19:(4):1998;240-247
31. Whang W., Bigger J.T.J. Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators. J Am Coll Cardiol. 36:(4):2000;1166-1172
32. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 329:(14):1993;977-986
33. Furnary A.P., Zerr K.J., Grunkemeier G.L., Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 67:(2):1999;352-360
34. Zerr K.J., Furnary A.P., Grunkemeier G.L., et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 63:(2):1997;356-361
35. DeCherney G.S., Maser R.E., Lemole G.M., et al. Intravenous insulin infusion therapies for postoperative coronary artery bypass graft patients. Del Med J. 70:(9):1998;399-404
36. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 345:(19):2001;1359-1367